Polyglutamine-induced ion channels: A possible mechanism for the neurotoxicity of Huntington and other CAG repeat diseases

被引:0
|
作者
Hirakura, Y
Azimov, R
Azimova, R
Kagan, BL
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Psychiat, Inst Neuropsychiat, Los Angeles, CA 90024 USA
[2] Brain Res Inst, Los Angeles, CA USA
[3] Mental Retardat Res Ctr, Los Angeles, CA USA
[4] Greater W Los Angeles VA Healthcare Syst, Los Angeles, CA USA
[5] Uzbek Acad Sci, Inst Physiol & Biophys, Tashkent 700135, Uzbekistan
关键词
pores; membranes; ataxia; amyloid;
D O I
10.1002/(SICI)1097-4547(20000515)60:4<490::AID-JNR7>3.0.CO;2-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
CAG repeats resulting in long polyglutamine tracts have been implicated in the pathogenesis of at least eight neurodegenerative diseases including Huntington. Expression of polyglutamine repeats is required for disease and increasing length of the repeats leads to earlier onset of illness (anticipation). Expression of polyglutamine repeats in cultured neurons leads to deposition of intracellular aggregates resembling those found in amyloid diseases, and to neurotoxicity. We report here that polyglutamine can induce large (19-220 pS), long-lived, (lifetime = 6 sec), non-selective (P-cation = P-anion) ion channels in planar phospholipid bilayer membranes, and that channel formation is enhanced by acidic pH. We propose that channel formation may be a mechanism of cellular toxicity in Huntington and other CAG repeat disease. Published 2000 Wiley-Liss, Inc.(dagger)
引用
收藏
页码:490 / 494
页数:5
相关论文
共 7 条
  • [1] Possible role of tissue transglutaminase (tTGase) in Huntington and other CAG expansion diseases
    Cooper, AJL
    Sheu, KFR
    Blass, JP
    JOURNAL OF NEUROCHEMISTRY, 1998, 70 : S7 - S7
  • [2] Targeting aggregation in the development of therapeutics for the treatment of Huntington's disease and other polyglutamine repeat diseases
    Steffan, JS
    Thompson, LM
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2003, 7 (02) : 201 - 213
  • [3] Age of onset in Huntington's disease is influenced by CAG repeat variations in other polyglutamine disease-associated genes
    Stuitje, Geerte
    van Belzen, Martine J.
    Gardiner, Sarah L.
    van Roon-Mom, Willeke M. C.
    Boogaard, Merel W.
    Tabrizi, Sarah J.
    Roos, Raymund A. C.
    Aziz, N. A.
    BRAIN, 2017, 140
  • [4] Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity
    Benjamin Anon
    Bérenger Largeau
    Alban Girault
    Aurélie Chantome
    Morgane Caulet
    Clémence Perray
    Driffa Moussata
    Christophe Vandier
    Chantal Barin-Le Guellec
    Thierry Lecomte
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 149 - 157
  • [5] Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity
    Anon, Benjamin
    Largeau, Berenger
    Girault, Alban
    Chantome, Aurelie
    Caulet, Morgane
    Perray, Clemence
    Moussata, Driffa
    Vandier, Christophe
    Barin-Le Guellec, Chantal
    Lecomte, Thierry
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (01) : 149 - 157
  • [6] Possible neuroprotective mechanism of resveratrol on 3-nitroproplonic acid-induced neurotoxicity, an animal model of Huntington's disease
    Kumar, A.
    Kumar, P.
    Padi, S. S., V
    Naidu, P. S.
    JOURNAL OF NEUROCHEMISTRY, 2006, 98 : 98 - 98
  • [7] Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains:: A possible mechanism contributing to CAG-triplet diseases
    Gentile, V
    Sepe, C
    Calvani, M
    Melone, MAB
    Cotrufo, R
    Cooper, AJL
    Blass, JP
    Peluso, G
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 352 (02) : 314 - 321